Antibody ABCs: Fully Human Antibodies

Summary

This video explains fully human antibodies, which are monoclonal antibodies composed entirely of human protein sequences, designed to reduce immune reactions while maintaining high specificity for their targets. It compares antibody types—murine, chimeric, humanized, and fully human—highlighting their origins and examples. The video details how fully human antibodies are generated using transgenic mice, phage or yeast display, or single B-cell cloning, with processes like VDJ recombination and affinity maturation. Bioendron's platforms for rapid antibody discovery and expression are showcased, emphasizing high diversity, throughput, and a three-month timeline to deliver fully human antibodies for therapeutic development.

Takeaways

• 🧬 Fully human antibodies are monoclonal antibodies composed entirely of human protein sequences, including both heavy and light chains.
• 🛡️ These antibodies are designed to minimize immunogenicity, reducing the likelihood of triggering an immune response against the therapeutic antibody itself.
• 🎯 Fully human antibodies maintain high specificity and affinity for their target antigens.
• 🐭 Murine antibodies are composed entirely of mouse sequences, such as murmonab CD3.
• 🔗 Chimeric antibodies combine non-human variable domains with human constant domains, examples include infliximab and rituximab.
• 🧩 Humanized antibodies have non-human CDRs grafted onto human frameworks, sometimes with back mutations; examples include trastuzumab, bevacizumab, and pembrolizumab.
• 🌱 Fully human antibodies are derived from human immunoglobulin genes using transgenic mice, phage or yeast display, or single B-cell cloning.
• 🧬 In transgenic mice, native mouse antibody genes are replaced with human gene segments, allowing normal immune processes to produce fully human antibodies.
• ⚡ Bioendron’s antibody expression platform can produce purified antibodies from gene sequence in just 2 weeks.
• 🚀 Bioendron’s high-throughput fully human antibody discovery platform, AppDrop, delivers fully human antibodies in only 3 months with high diversity and unique binders.
• 💡 Antibody classification is based on sequence origin, which influences immunogenicity and therapeutic application.
• 🔬 The combination of VDJ recombination, somatic hypermutation, and affinity maturation in transgenic mice ensures production of high-quality fully human antibodies.

Q & A

What are fully human antibodies?

Fully human antibodies are monoclonal antibodies composed entirely of human protein sequences, including both heavy and light chain variable and constant regions.

Why are fully human antibodies important in therapeutic development?

They are designed to minimize immunogenicity, reducing the likelihood that the patient's immune system will recognize and attack the therapeutic antibody.

What does immunogenicity mean in the context of antibody therapeutics?

Immunogenicity refers to the ability of a therapeutic antibody to trigger an immune response against itself in the patient.

How are antibodies classified by sequence origin?

Antibodies are classified as murine, chimeric, humanized, or fully human based on the proportion of human versus non-human protein sequences they contain.

What are murine antibodies?

Murine antibodies are antibodies made entirely from mouse protein sequences. An example mentioned in the script is muromonab-CD3.

What are chimeric antibodies?

Chimeric antibodies contain non-human variable domains fused with human constant domains. Examples include infliximab, rituximab, and cetuximab.

How are humanized antibodies different from chimeric antibodies?

Humanized antibodies usually contain only non-human complementarity-determining regions (CDRs) grafted onto mostly human antibody frameworks, while chimeric antibodies retain entire non-human variable domains.

What are some examples of humanized antibodies mentioned in the script?

Examples mentioned include trastuzumab, bevacizumab, and pembrolizumab.

How are fully human antibodies generated?

They can be generated using transgenic mice, phage or yeast display technologies, or single B-cell cloning methods.

What happens in transgenic mice used for fully human antibody discovery?

The mice have their native murine antibody genes inactivated and replaced with human immunoglobulin gene segments, allowing them to produce fully human antibodies after immune stimulation.

What biological processes occur in transgenic mice during antibody generation?

The mice undergo V(D)J recombination, somatic hypermutation, and affinity maturation, which help create highly specific and high-affinity antibodies.

Why are fully human antibodies considered advantageous over murine antibodies?

Fully human antibodies are less likely to cause immune reactions in patients and generally have improved compatibility for long-term therapeutic use.

What is the purpose of antibody affinity maturation?

Affinity maturation improves the binding strength and specificity of antibodies toward their target antigens.

What services does Biointron provide in antibody development?

Biointron focuses on antibody discovery, expression, and optimization services for therapeutic antibody development.

How quickly can Biointron produce purified antibodies using its expression platform?

According to the script, Biointron can produce purified antibodies from gene sequence in just 2 weeks.

What is the advantage of Biointron’s CellCept Alpaca platform?

The platform provides unique binders, high diversity, and large-capacity VH antibody discovery capabilities.

What is AppDrop according to the script?

AppDrop is Biointron’s high-throughput fully human antibody discovery platform that can deliver fully human antibodies within 3 months.

What role do B cells play in fully human antibody production?

B cells in transgenic mice secrete fully human monoclonal antibodies after exposure to an antigen, which can then be isolated and cloned for therapeutic use.